NanoLogix Inc (NNLX)
0.00
USD |
OTCM |
May 01, 16:00
NanoLogix Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 100.00% |
March 31, 2023 | 100.00% |
February 28, 2023 | 100.00% |
January 31, 2023 | 100.00% |
December 31, 2022 | 100.00% |
November 30, 2022 | 100.00% |
October 31, 2022 | 100.00% |
September 30, 2022 | 100.00% |
August 31, 2022 | 100.00% |
July 31, 2022 | 100.00% |
June 30, 2022 | 100.00% |
May 31, 2022 | 100.00% |
April 30, 2022 | 100.00% |
Date | Value |
---|---|
March 31, 2022 | 100.00% |
February 28, 2022 | 100.00% |
January 31, 2022 | 100.00% |
December 31, 2021 | 100.00% |
November 30, 2021 | 99.95% |
October 31, 2021 | 99.95% |
September 30, 2021 | 99.95% |
August 31, 2021 | 91.50% |
July 31, 2021 | 91.32% |
June 30, 2021 | 91.32% |
May 31, 2021 | 94.55% |
April 30, 2021 | 94.73% |
March 31, 2021 | 95.53% |
February 28, 2021 | 96.18% |
January 31, 2021 | 96.18% |
December 31, 2020 | 96.18% |
November 30, 2020 | 96.18% |
October 31, 2020 | 96.18% |
September 30, 2020 | 96.18% |
August 31, 2020 | 96.18% |
July 31, 2020 | 96.18% |
June 30, 2020 | 96.18% |
May 31, 2020 | 96.28% |
April 30, 2020 | 96.72% |
March 31, 2020 | 97.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
91.32%
Minimum
Jun 2021
100.00%
Maximum
Dec 2021
98.22%
Average
99.95%
Median
Sep 2021
Max Drawdown (5Y) Benchmarks
AIM ImmunoTech Inc | 99.76% |
Perspective Therapeutics Inc | 91.70% |
Protalix BioTherapeutics Inc | 94.35% |
Electromed Inc | 55.84% |
Armata Pharmaceuticals Inc | 99.87% |